Interleukin-6 in the injured patient marker of injury or mediator of inflammation?

被引:457
作者
Biffl, WL
Moore, EE
Moore, FA
Peterson, VM
机构
[1] DENVER GEN HOSP, DEPT SURG, DENVER, CO 80204 USA
[2] UNIV COLORADO, HLTH SCI CTR, DENVER, CO USA
关键词
D O I
10.1097/00000658-199611000-00009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective The effects of interleukin (IL)-6 in the injured patient are examined in an attempt to clarify the potential pathophysiologic role of IL-6 in the response to injury. Summary Background Data Interleukin-6 is an integral cytokine mediator of the acute phase response to injury and infection. However, prolonged and excessive elevations of circulating IL-6 levels in patients after trauma, burns, and elective surgery have been associated with complications and mortality. The mechanistic role of IL-6 in mediating these effects is unclear. Methods A review of current literature is performed to summarize the origins, mechanisms of action, and biologic effects of IL-6 and to characterize the IL-6 response to injury. Results Interleukin-6 is a multifunctional cytokine expressed by a variety of cells after a multitude of stimuli, under complex regulatory control mechanisms. The IL-6 response to injury is uniquely consistent and related to the magnitude of the insult. Moreover, the early postinjury IL-6 response correlates with complications as well as mortality. Conclusions Interleukin-6 appears to play an active role in the postinjury immune response, making it an attractive therapeutic target in attempts to control hyperinflammatory provoked organ injury.
引用
收藏
页码:647 / 664
页数:18
相关论文
共 256 条
[121]   INTRATHECAL AND SERUM INTERLEUKIN-6 AND THE ACUTE-PHASE RESPONSE IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURIES [J].
KOSSMANN, T ;
HANS, VHJ ;
IMHOF, HG ;
STOCKER, R ;
GROB, P ;
TRENTZ, O ;
MORGANTIKOSSMANN, MC .
SHOCK, 1995, 4 (05) :311-317
[122]  
KOWALVERN A, 1994, J AM COLL SURGEONS, V178, P357
[123]   REGULATION OF ICAM-1 AND IL-6 IN MYOCARDIAL-ISCHEMIA - EFFECT OF REPERFUSION [J].
KUKIELKA, GL ;
YOUKER, KA ;
HAWKINS, HK ;
PERRARD, JL ;
MICHAEL, LH ;
BALLANTYNE, CM ;
SMITH, CW ;
ENTMAN, ML .
CELLULAR, BIOCHEMICAL, AND MOLECULAR ASPECTS OF REPERFUSION INJURY, 1994, 723 :258-270
[124]  
KUPPER TS, 1989, ANN NY ACAD SCI, V557, P454
[125]  
LE JM, 1989, LAB INVEST, V61, P588
[126]  
LEALBERUMEN I, 1994, J IMMUNOL, V152, P5468
[127]  
LEEUWENBERG JFM, 1990, J IMMUNOL, V145, P2110
[128]   LIMITED INVOLVEMENT OF INTERLEUKIN-6 IN THE PATHOGENESIS OF LETHAL SEPTIC SHOCK AS REVEALED BY THE EFFECT OF MONOCLONAL-ANTIBODIES AGAINST INTERLEUKIN-6 OR ITS RECEPTOR IN VARIOUS MURINE MODELS [J].
LIBERT, C ;
VINK, A ;
COULIE, P ;
BROUCKAERT, P ;
EVERAERDT, B ;
VANSNICK, J ;
FIERS, W .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (10) :2625-2630
[129]   THE INFLUENCE OF MODULATING SUBSTANCES ON TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-6 LEVELS AFTER INJECTION OF MURINE TUMOR-NECROSIS-FACTOR OR LIPOPOLYSACCHARIDE IN MICE [J].
LIBERT, C ;
VANBLADEL, S ;
BROUCKAERT, P ;
FIERS, W .
JOURNAL OF IMMUNOTHERAPY, 1991, 10 (04) :227-235
[130]   INTERLEUKIN-6 [J].
LOTZ, M .
CANCER INVESTIGATION, 1993, 11 (06) :732-742